The global self-monitoring blood glucose devices market was valued at $8,490.79 million in 2019, and is projected to reach $11,991.98 million by 2027, growing at a CAGR of 4.2% from 2020 to 2027.
With diabetes on the rise, people are increasingly turning to alert programs that combine innovative technology and connected devices with human coaches and support. Teladoc Health, one of the ...